Investors Encouraged to Inquire About Securities Class Action Investigation Against GeneDx Holdings Corp.
PorAinvest
domingo, 17 de agosto de 2025, 9:49 pm ET1 min de lectura
WGS--
The investigation stems from a report published by Grizzly Research on February 5, 2025, titled "Insiders Attest that GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud." The report alleged that GeneDx's growth is largely an illusion, driven by fraudulent schemes and illegal tactics aimed at exploiting Medicaid and Medicare systems to artificially inflate revenue. Following this report, GeneDx's stock fell by 6.7% on February 5, 2025 [1].
Investors who purchased GeneDx securities may be entitled to compensation without incurring any out-of-pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. Interested investors can join the prospective class action by visiting [https://rosenlegal.com/submit-form/?case_id=40333](https://rosenlegal.com/submit-form/?case_id=40333) or by contacting Phillip Kim, Esq. toll-free at 866-767-3653 or via email at case@rosenlegal.com [2].
The Rosen Law Firm is known for its expertise in securities class actions and shareholder derivative litigation. The firm has recovered hundreds of millions of dollars for investors and has been ranked in the top 4 each year since 2013. In 2019 alone, the firm secured over $438 million for investors [3].
References:
[1] https://www.morningstar.com/news/pr-newswire/20250813dc51052/rosen-law-firm-encourages-genedx-holdings-corp-investors-to-inquire-about-securities-class-action-investigation-wgs
[2] https://www.marketscreener.com/news/rosen-nationally-regarded-investor-counsel-encourages-genedx-holdings-corp-investors-to-inquire-a-ce7c51dfdc8bf72c
[3] https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-genedx-holdings-corp-investors-to-inquire-about-securities-class-action-investigation--wgs-302529374.html
GeneDx Holdings Corp. is being investigated for potentially misleading business information to investors. Shareholders may be entitled to compensation through a contingency fee arrangement. To join the prospective class action, visit https://rosenlegal.com/submit-form/?case_id=40333 or call Phillip Kim, Esq. at 866-767-3653 or email case@rosenlegal.com. The Rosen Law Firm is representing investors globally and has a track record of success in securities class actions and shareholder derivative litigation.
GeneDx Holdings Corp. (NASDAQ: WGS) investors are being encouraged to inquire about a potential securities class action investigation. The Rosen Law Firm, a globally recognized investor rights law firm, is investigating allegations that GeneDx may have issued materially misleading business information to the investing public.The investigation stems from a report published by Grizzly Research on February 5, 2025, titled "Insiders Attest that GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud." The report alleged that GeneDx's growth is largely an illusion, driven by fraudulent schemes and illegal tactics aimed at exploiting Medicaid and Medicare systems to artificially inflate revenue. Following this report, GeneDx's stock fell by 6.7% on February 5, 2025 [1].
Investors who purchased GeneDx securities may be entitled to compensation without incurring any out-of-pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. Interested investors can join the prospective class action by visiting [https://rosenlegal.com/submit-form/?case_id=40333](https://rosenlegal.com/submit-form/?case_id=40333) or by contacting Phillip Kim, Esq. toll-free at 866-767-3653 or via email at case@rosenlegal.com [2].
The Rosen Law Firm is known for its expertise in securities class actions and shareholder derivative litigation. The firm has recovered hundreds of millions of dollars for investors and has been ranked in the top 4 each year since 2013. In 2019 alone, the firm secured over $438 million for investors [3].
References:
[1] https://www.morningstar.com/news/pr-newswire/20250813dc51052/rosen-law-firm-encourages-genedx-holdings-corp-investors-to-inquire-about-securities-class-action-investigation-wgs
[2] https://www.marketscreener.com/news/rosen-nationally-regarded-investor-counsel-encourages-genedx-holdings-corp-investors-to-inquire-a-ce7c51dfdc8bf72c
[3] https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-genedx-holdings-corp-investors-to-inquire-about-securities-class-action-investigation--wgs-302529374.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios